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Characteristic changes in cell morphology paralleled by the appearance of a multitude of molecular and biochemical markers occur 
during apoptosis. These changes vary depending on the cell type, mechanism of induction of apoptosis, and the time-window at which 
the process of apoptosis is analyzed. By virtue of the capability of rapid measurement of individual cells the flow- and imaging-
cytometry become preferred technologies to detect, identify and record incidence of apoptosis in large cell populations. It also 
provided a valuable tool to investigate molecular mechanisms in field of necrobiology. This review outlines the progress in develop-
ment of the most commonly used cytometric methods probing cells death based on analysis of fragmentation of DNA, activation 
of caspases, analysis of mitochondrial potential, alterations in plasma membrane structure and other features that characterize 
programmed cell death. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
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INTRODUCTION
This review is focused on the progress in deve­
lopment of cytometric methods pro�ing apoptotic 
cell death. The term apoptosis is used here to define 
the “classical” apoptotic process� initially also called 
programmed cell death� which is inclusive of such 
hallmarks as: �I� mitochondrial changes manifesting 
�y collapse of the transmem�rane electrochemical 
potential and release of cytochrome c to cytosol� �II� 
activation of caspases� �III� chromatin condensation 
�pycnosis�� �IV� activation of endonucleas�s� followed 
�y internucleosomal DNA cleavage� �V� segregation 
of nucleoli� �VI� fragmentation of nucleus� and �VII� 
plasma mem�rane �le��ing associated with formation 
of apoptotic �odies [�� �]. 
It should �e noted� however� that with passing time 
it �ecame apparent that in addition to cell death that 
demonstrates “classical” features of apoptosis there 
are other ways of cell demise that also involve ac­
tive participation of the cell [��7]. The most recently 
recognized modes of cell death include: �I� extrinsic 
apoptosis� intrinsic apoptosis that is either �II� cas­
pase­dependent or �III� ­independent� �IV� regulated 
necrosis� �V� autophagic cell death and �VI� mitotic 
catastrophe [�]. Different mechanisms operate in each 
of these death modes� and this is reflected �y some­
what different character of changes in cell morphology� 
expression of different molecular markers and some 
specific features. It is of importance� therefore� when 
descri�ing cell death in general or apoptosis in par­
ticular� to define with as much detail as possi�le� the 
�iomarkers that served to classify the mode of death. 
The term “cell necro�iology” ��iology of cell death� 
was proposed to encompass different modes of cell 
death� the range of stress signaling cascades leading 
to cell death� regulatory mechanisms� initiation� and 
execution steps of cell death� as well as cell remnants 
disposal mechanisms� all associated with cell demise 
[8���; see Cell Necrobiology in Wikipedia].
THE FIRST MARKERS ANALYZED 
BY CYTOMETRY — LIGHT SCATTER 
CHANGES, DNA FRAGMENTATION AND 
CHROMATIN CONDENSATION 
The highly characteristic morphological changes 
that occur during apoptosis provided specific mar­
kers for identification of this mode of cell death prior 
to use of flow cytometry [�� �]. Among the predominant 
features of apoptotic cells were their diminished size 
�as a result of dehydration�� condensation of chromatin 
�often starting from nuclear periphery and forming 
“crescent moon” appearance�� segregation of nucle­
oli� nuclear fragmentation and formation of apoptotic 
�odies [�� �]. For several years these changes� consi­
dered the “gold standard” for recognition of apoptosis� 
served as markers for identification of apoptotic cells 
and used for assessment of frequency of apoptosis. 
Another hallmark of apoptosis was activation of endo­
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nuclease that led to internucleosomal DNA clea vage 
and extensive fragmentation of nuclear DNA [�]. 
In these early studies� apoptosis­related fragmenta­
tion of DNA was recognized �y a characteristic pat­
tern of DNA “laddering” that revealed the presence 
of mono­ and multi­nucleosomal size DNA fragments 
during gel electrophoresis [�].
The possi�ility of rapid measurement of individual 
cells in large cell populations offered �y flow cytom­
etry made it the methodology of choice to identify and 
quantify apoptotic cells as well as to study mechanisms 
associated with this mode of cell death [7���]. The 
change in light scattering properties of cells dying 
�y apoptosis was one of the earliest o�servations and 
served as a marker identifying apoptotic cells. �pecifi­
cally� it was o�served that at early stage of apoptosis 
the cell is characterized �y distinctly reduced a�i lity 
to scatter light in forward direction and �y an in­
crease in intensity in side �9�° angle� scatter signal 
[��]. While forward light scatter reports cell size� the 
intensity of side light scatter relates to reflective and 
refractive properties of the cell. These early changes 
in forward light scatter are a result of cell shrinkage� 
whereas changes in side scatter reflect chromatin 
condensation� nuclear fragmentation and crosslinking 
of cytoplasmic proteins �y activated transglutaminase� 
making the cell more refractive and reflective. At later 
stages of apoptosis� when cells shed­off apoptotic 
�odies and further reduce their size� the intensity 
of �oth� the forward and right angle light scatter signal 
�ecome markedly decreased. The virtue of the assay 
�ased on light scatter measurement is its simplicity and 
the possi�ility of its com�ination with analysis of the 
cells surface immunophenotype [��] and/or with func­
tional assays such as the mitochondria� potential� cal­
cium signaling or exclusion of charged fluorochromes 
�y plasma mem�rane. It should �e stressed� however� 
that the decreased forward light scatter signal is not 
a specific marker of apoptosis since mechanically 
�roken and fragmented cells� isolated cell nuclei� and 
necrotic cells also have reduced light scatter proper­
ties. This approach� therefore� should �e accompanied 
�y another� more specific assay of apoptosis. 
Activation of endonuclease that cleaves DNA at in­
ternucleosomal �linker� sections� one of the most char­
acteristic events of apoptosis [�� ��]� was also among 
the first markers of apoptosis recognized �y flow 
cytometry. The low molecular weight �MW� fragments 
of DNA �mono­ and oligo­nucleosomal sections� leak 
out from the ethanol­fixed or detergent­permea�ilized 
apoptotic cells during rinse and staining procedures. 
The events with fractional DNA content recorded 
�y flow cytometry� represented �y the “su�­G�” peaks 
on the DNA content histograms� were considered 
to �e apoptotic cells [�����]. It should �e noted� how­
ever� that the detergent treatment of the unfixed cells 
as proposed in some studies [��] in addition to the 
intact nuclei� releases also individual nuclear/chro­
matin fragments. Therefore the num�er of the su�­
G� events on DNA content frequency histograms from 
the assays utilizing detergent­permea�ilized cells may 
severely overestimate incidence of apoptosis [�7]. This 
is particularly pronounced when the DNA content his­
tograms are plotted on exponential scale which allows 
one to detect and quantify o�jects having even less 
that �% of DNA of the intact G� cells� which certainly 
cannot �e individual apoptotic cells. The approach 
to identify apoptotic cells �ased on fractional DNA 
content was later advanced �y selective extraction 
of low MW DNA �mono­ and oligo­nucleosomal� from 
the ethanol­fixed cells using �uffer of high molarity. 
A com�ination of analysis of fragmentation of so ex­
tracted DNA �y gel electrophoresis �“DNA laddering”� 
with the flow­cytometric detection of apoptotic cells 
�ased on their fractional DNA content after DNA ex­
traction offered a complementary �iochemical �DNA 
“laddering”� and cytometric �su�­G�� methodology 
of the same samples [�7].
Furtner approach to identify apoptotic cells was 
�ased on the detection of DNA strand �reaks in the 
nuclei �y la�eling their �’OH termini with �iotin­ or di­
goxigenin­conjugated nucleotides in the enzymatic 
reaction catalyzed �y exogenous terminal deoxynu­
cleotidyl transferase �TdT� [�8� �9]. This methodology 
is also known as the TdT dUTP nick end la�eling 
�TUNEL� assay [��]. It should �e mentioned� how­
ever� that the acronym TUNEL is inaccurate �ecause 
the DNA dou�le­strand �reaks �ds� and not the “nicks” 
�single­strand �reaks — ss� are �eing la�eled and 
instead of dUTP other deoxynucleotides are used 
in most types of these assays [�8� �9]. The alterna­
tive approach to la�el DNA strand �reaks �y the nick 
translation assay utilizing DNA polymerase I was less 
successful [�8� ��]. Currently� the most widely used 
and also the most sensitive assay utilizes BrdUTP 
as the TdT su�strate for la�eling DNA strand �reaks 
[��]. It should �e noted that unlike in the case of de­
tecting apoptotic cells �ased on their fractional DNA 
content �su�­G�� the cells su�jected to the TdT assay 
have to �e pre­fixed in formaldehyde to crosslink DNA 
and there�y prevent its leakage out from the cell. 
Concurrent differential la�eling of DNA strand �reaks 
and DNA provides a convenient assay to correlate 
induction of apoptosis with the cell cycle phase [�9� 
��]. Analysis of such correlation is helpful in exploring 
mechanism of action of anticancer drugs that target 
cell cycle progression machinery [��]. 
Among other early cytometric methods identifying 
apoptotic cells was the one which recognizes them 
�y the virtue of detection of intense chromatin conden­
sation [��]. Chromatin condensation is characterized 
�y the increased suscepti�ility of DNA in situ to un­
dergo denaturation �“melting”� when stressed �y heat 
or acid. The extent of DNA denaturation in situ was as­
sessed with the metachromatic fluorochrome acridine 
orange� which interacts with dsDNA yielding green­� 
and with ss �denatured� DNA� red­fluorescence [��].
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ACTIVATION OF CASPASES
Development of the methods designed to detect 
activation cysteine­aspartic acid­specific proteases 
�caspases� was also among the early attempts to ex­
plore applications of cytometry in studies of apoptosis. 
Caspases activation� which occurs at relatively early 
stages of apoptosis� has �een considered to �e also 
a hallmark of this mode of cell death [��� ��]. As men­
tioned� however� it was later found that the process 
of apoptosis may also �e caspase­independent [��7]. 
Many different methods detecting caspase activation 
have �een developed and widely used in �asic and 
clinical studies. One of the early approaches utilized 
fluorogenic su�strates of these enzymes. These 
peptide su�strates are not fluorescent �ut following 
the caspase­induced cleavage the products show 
strong fluoresce [�7���]. A num�er of kits of these 
reagents having different color fluorochromes have 
�een developed and �ecame commercially availa�le. 
Depending on the peptide specificity these su�strates 
can �e used to detect activation of either multiple 
or individual caspases� respectively. 
Another approach to detect activation of caspases 
is �ased on the immunocytochemical detection of the 
cleaved poly�ADP­ri�ose� polymerase �PARP�� one 
of the “death su�strates” of caspases. In live cells the 
nuclear enzyme PARP �ecomes activated in response 
to DNA damage and functions during DNA repair [��]. 
At early stage of apoptosis� however� PARP is cleaved 
�y caspases and the specific cleavage products are 
89­kDa and ��­kDa PARP fragments [��� ��]. Detec­
tion of these protein products �y Western �lotting� 
in analogy to DNA “laddering” assay was considered 
to �e a specific �iochemical marker of apoptotic mode 
of cell death. However� the immunocytochemical de­
tection of the 89­kDa product of the PARP cleavage 
provided the means to la�el apoptotic cells for their 
recognition �y cytometry [��]. The multiparameter 
analysis of the cells differentially stained for PARP 
p89 and DNA made it possi�le to correlate the induc­
tion of apoptosis with the cell cycle phase or DNA 
ploidy [��]. 
�till another way to detect activation of caspases 
is �ased on immunocytochemical detection of the 
epitope of the activated �cleaved� caspases. A�s 
specific to several activated caspases have �een de­
veloped and initially used for detection of apoptosis 
�y Western �lotting. �u�sequently these A�s were 
adapted to cytometry to identify apoptotic cells. De­
tection of caspase­�� one of the “cell executioners” 
caspases� with its A� was found to �e particularly 
useful to reveal its activation and as an overall marker 
of apoptotic mode of cell death. In analogy to PARP 
p89 A�� immunocytochemical detection of cas­
pase­� concurrent with counterstaining of DNA with 
another color fluorochrome made it possi�le to relate 
induction of apoptosis with the cell cycle phase �y flow 
cytometry [��� ��].
Activation of caspases can also �e detected with 
the use of fluorochrome­la�eled inhi�itors of cas­
pases �FLICA� [��� ��]. FLICAs are the affinity ligands 
to the active enzyme centers of caspases. Each 
FLICA has three functionally different domains: �I� the 
fluorochrome �fluorescein or sulforhodamine�� �II� four 
amino­acid peptide providing the individual caspase 
recognition domain� and �III� either chloro­ or fluoro­
methyl ketone �CMK or FMK� that �inds irreversi�ly 
to cysteine of the active center of respective cas­
pase. FLICAs are permeant to live cells and nontoxic. 
Exposure of live cells to FLICAs leads to the uptake 
of these reagents followed �y their covalent �inding 
to activated caspases; un�ound FLICAs are removed 
from the cells that lack activated caspases �y rinsing 
the cells. Com�ination of FLICA and propidium iodide 
�PI�� the plasma mem�rane integrity pro�e� provides 
the possi�ility to distinguish three consecutive stages 
of apoptosis. FLICA may also �e used concurrently 
with a pro�e of mitochondrial potential as well as with 
other pro�es that are applica�le to either live or fixed 
cells [��]. It was recently o�served that FLICAs �de­
fined as FLIVO reagents� can �e used in vivo to detect 
apoptosis in mouse tissues [�7]. 
The use of the tandem molecules of green fluores­
cent protein �GFP� and �lue fluorescent protein �BFP�� 
or cyan­ �CFP� and yellow­fluorescent protein �YFP�� 
covalently linked �y a short peptide that is the target 
of caspase� represents still another approach to de­
tect caspases activation [�8� �9]. The fluorescence 
resonance energy transfer �FRET� normally occurs 
�etween the pairs of these fluorescent proteins when 
they are linked �y the peptide. However� after cleavage 
of the peptide linker �y activated caspase the linkage 
is disrupted leading to loss of FRET fluorescence. 
Because in this case the marker of caspase activa­
tion is intrinsic� operating in the live cell� the method 
is simple� rapid and not requiring fixation or application 
of external reagents. The collection of cell lines sta�ly 
transfected to constitutively express the tandems 
of FRET fluorescing proteins would �e particularly use­
ful for drug screening �y monitoring apoptosis of the 
drug treated cells in real time.
MITOCHONDRIAL ELECTROCHEMICAL 
TRANSMEMBRANE POTENTIAL
Mitochondria play an essential role in induction 
of apoptosis �y releasing cytochrome c� apoptosis­
inducing factor �AIF� and variety of other apoptosis­
associated molecules that initiate the cascade 
of caspases activation [�����]. The release occurs 
as a consequence of mitochondrial outer mem�rane 
permea�ilization �MOMP� resulting from change 
in equili�rium of pro­ versus anti­apoptotic molecules 
of the Bcl­� family of proteins. Dissipation of mito­
chondrial inner mem�rane electrochemical potential 
�ΔΨm� called also permea�ility transition �PT� appears 
to �e associated with MOMP� although there is conflict­
ing evidence as to whether it is a prerequisite for the 
release of cytochrome c and activation of caspases 
[�����]. The conflicting data may �e due to the fact 
that PT is a transient event that initially occurs con­
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currently with MOMP� then mitochondria �ecame 
re­charged� �ut su�sequently with progression of the 
apoptotic process� the ΔΨm dissipates again. 
Different fluorescent pro�es reporting ΔΨm have 
�een adapted to flow cytometry. Historically� the first 
was rhodamine ���� which when used in com�ination 
with PI� provided a sensitive marker distinguishing 
two stages of cell death� revealed �y �I� loss of ΔΨm 
followed �y �II� loss of plasma mem�rane a�ility 
to exclude PI. Through this approach it was possi�le 
to discriminate �etween apoptotic and necrotic mode 
of cell death [�7]. Another� widely used pro�e� was the 
cationic lipophilic dye ���’­dihexiloxa­dicar�ocyanine 
[DiOC� ���] [�8]. �u�sequently� a series of MitoTrack­
erTM fluorochromes �chloromethyltetramethylrosamine 
analogues� of different fluorescence emission color 
were developed �y Molecular Pro�es Inc �Eugene� 
OR� U�A�. One of them� MitoTracker Red CMXRos� 
appears to �e very sensitive pro�e of ΔΨm and un­
like DiOC� ��� or rhodamine ���� remains retained 
in the cell after fixation with formaldehyde [�9]. It can 
�e used therefore in com�ination with the markers that 
require cell fixation such as TUNEL or detection of in­
tracellular protein�s� �y immunocytochemical pro�es. 
Another useful pro�e of ΔΨm� analogous to MitoTracker 
Red CMXRos� is tetramethylrhodamine methyl ester 
perchlorate �TMRM�. The latter� in com�ination with 
FLICA was shown to �e a�le to detect the sequence 
of time­resolved apoptotic events� namely the dissipa­
tion of mitochondrial potential followed �y activation 
of caspases [��]. 
 Another type of ΔΨm pro�es are lipophilic cationic 
fluorochromes that form so called J­aggregates� such 
as ���’����’­tetrachloro­���’����’­tetraethyl�enzimid­
azolcar�ocyanine iodide �JC­�� and ���’­dimethyl­α­
nafthoxacar�oxycyaninine iodide �JC­9�. Their uptake 
�y charged mitochondria leads to dye aggregation 
which is reported �y the metachromatic shift from 
green to orange/red fluorescence. The loss of ΔΨm dur­
ing apoptosis leads to dissociation of the J­aggregates 
and in the monomeric form these pro�es show green 
fluorescence [��]. 
The point to �e considered while measuring ΔΨm 
is that the distri�ution �concentration gradient� of the 
cationic mitochondrial pro�es reflects the electro­
chemical potential differences �oth across the plasma 
mem�rane and across mitochondrial mem�ranes. 
The pro�es thus accumulate in mitochondria as well 
as in cytosol. The relative proportion in their distri�u­
tion �etween cytosol and mitochondria thus depends 
not only on mitochondrial potential �ut also on charge 
of plasma mem�rane and a�undance of cytosol. The 
contri�ution of fluorescence from cytosol is therefore 
affecting mitochondria­related specificity of the mea­
sured ΔΨm. The J­aggregates pro�es �JC­�� JC­9� 
which do not form the aggregates in cytosol� appear 
thus to have an advantage �eing more specific mi­
tochondrial pro�es than rhodamine ���� DiOC� ��� 
or MitoTrackerTM dyes [��]. 
ANNEXIN V BINDING 
In live cells distri�ution of the phospholipids phos­
phatidylcholine and sphingomyelin� constituents 
of plasma mem�rane� is asymmetrical across the 
mem�rane. While phosphatidylcholine is exposed 
externally phosphatidylserine is located on the inner 
surface the lipid �ilayer. This asymmetry disappears 
during apoptosis when� to make apoptotic cells more 
attractive targets to �e engulfed �y macrophages� 
phosphatidylserine �ecomes exposed on the outside 
leaflet of the mem�rane [��� ��]. The anticoagu­
lant protein annexin V shows high affinity in �inding 
to phosphatidylserine. The methodology was deve­
loped� therefore to use the fluorochrome­conjugated 
annexin V as a marker of apoptosis [��� ��]. After 
induction of apoptosis the expression of phosphatidyl­
serine on external surface of plasma mem�rane occurs 
prior to the loss of its a�ility to exclude cationic dyes 
such as PI. At early stages of apoptosis therefore cells 
�ind annexin V �ut exclude PI. At later stages the cells 
show �oth� annexin V �inding and PI fluorescence. 
The virtue of this methodology is simplicity. Cur­
rently� this is perhaps the most widely used cytometric 
method to detect apoptosis. The results o�tained 
�y this method� however� may �e �iased �y the pres­
ence of non­apoptotic cells having damaged plasma 
mem�rane with the exposed phosphatidylserine that 
�inds annexin V. �pecifically� cell isolation �y mechani­
cal or enzymatic disaggregation of tissues� extensive 
use of proteolytic enzymes to detach adherent cells� 
mechanical removal of cells from tissue culture flasks 
�e.g. �y “ru��er policeman”�� cell electroporation 
or transfection� all may affect the asymmetry of plas­
ma mem�rane phospholipids and lead to �inding 
of annexin V �y non­apoptotic cells. It should also 
�e stressed that otherwise live and healthy macro­
phages or monocytes� after ingestion of apoptotic 
�odies or fragments of apoptotic cells �ecome annexin 
V positive and thus may �e misidentified as apoptotic 
cells [��]. This pro�lem� however� is not unique for 
the methodology �ased on the use of annexin V. It was 
o�served that using TUNEL or FLICA assays as well 
the engulfment of apoptotic cells �y macrophages 
makes them “false positive apoptotic cells” during flow 
cytometric analysis [��� ��]. 
SYTO PROBES 
Progress has recently �een made �y the devel­
opment of cell permeant� cyanine �YTO stains and 
their exploitation for quantification of apoptosis 
using flow cytometry [�9� �7��9]. This novel class 
of cyanine pro�es spans a �road range of vis­
i�le excitation and emission spectra: �� �YTO �lue 
�Ex/Em 419–452/445–484 nm�; �� �YTO green 
�Ex/Em 483–521/500–556 nm�; �� �YTO orange 
�Ex/Em 528–567/544–583 nm� and �� �YTO red 
�Ex/Em 598–654/620–680 nm� [�9� ��]. Their low 
cost offers an advantage for �road application in the 
first line screening of novel therapeutics with cyto­
toxic properties� particularly antitumor drugs targeting 
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apoptotic pathways� whereas spectral characteristics 
make them highly amena�le for development of new 
multiparameter/multiplexed assays [�7���]. Following 
initiation of caspase­dependent apoptosis cells loaded 
with selected �YTO fluorochromes exhi�it gradual re­
duction in fluorescence signal intensity to dim values 
[�7���]. This phenomenon su�stantially precedes 
plasma mem�rane permea�ility changes. When 
progression towards the terminal stages of cellular 
demise advances� loss of �YTO fluorescence inten­
sifies� and this usually coincides with the increased 
plasma mem�rane permea�ility to PI. The assay 
requires only a short incu�ation ��� min� at room 
temperature� to supravitally discriminate via�le cells 
��YTOhigh / PI­ events� [�7���]. Early apoptotic cells are 
characterized �y initial loss of �YTO fluorescence and 
preservation of plasma mem�rane integrity ��YTOdim 
/ PI­ events� [�7���]. Cells in late stages of apoptosis 
feature progressive loss of �YTO fluorescence and gain 
�right PI staining ��YTOneg / PI+ events�.
Interestingly� our knowledge on the fundamental 
mechanisms �ehind differential staining of �YTO 
la�eled apoptotic versus via�le cells still remains 
am�iguous [�7� �9]. To date several hypotheses 
have �een put forward and include: �I� self­quenching 
of �YTO molecules that follows changes in inter­pro�e 
proximity during apoptotic chromatic condensation; 
�II� decrease in the num�er of �YTO �inding sites as the 
chromatin condensation and/or RNA degradation 
advances in the process of apoptosis; �III� alterations 
in �inding of �YTO to mitochondrial DNA; and �IV� 
decrease in Δψm­driven mitochondrial uptake of �YTO 
molecules [�9]. Despite this �YTO ��/PI assay has re­
cently �een reported to allow discrimination �etween 
primary and secondary necrotic cells [�7]. Therefore 
�YTO ��/PI assays provides su�stantial enhancement 
over the standard PI exclusion assay in discerning cell 
demise mode �y flow cytometry [�9� ��]. Recently 
pu�lished data also indicate that sensitivity of �YTO 
pro�es in detection of early apoptotic events is equal 
or in some models higher as compared to Annexin V� 
YO­PRO � or FLICA assays [�9� �9]. A caution should 
�e� however� exercised as �YTO pro�es are effective 
su�strates for P­glycoprotein �P­gp� efflux pump [�7� 
�9� ��]. Hence there is a need to confirm “multi drug 
resistance” �MDR� status of studied cell population. 
In cells with confirmed high P­gp activity its inhi�ition 
�e.g. �y verapamil hydrochloride� is advisa�le to avoid 
masking of apoptotic �YTOdim su�population �y �YTOdim 
su�population resulting from active dye efflux [�7� �9� 
��]. It should �e mentioned that high efflux activity 
driven �y P­gp in certain cells may also complicate 
interpretation of other assays that are �ased on the 
intake of fluorescent pro�es �y live cells.
REAL-TIME ANALYSIS OF APOPTOSIS
Most contemporary cell death assays are per­
formed in the “end­point” fashion that only reveals 
frequency of live versus dead cells at the time of har­
vesting or at the intermittent and su�jective time­
points during cell culture [��]. Cell death within cell 
populations is� however� a stochastic process where 
cell­to­cell varia�ility in time �etween the varying 
stages of cell death arises from the su�tle fluctuations 
in the concentrations or states of regulatory proteins� 
protein oscillations� the induction of multiple compen­
satory mechanisms �e.g. autophagy�� or “molecular 
noise” [��� ��]. The possi�ility to continuously track 
cells from the time of encountering stress signal� 
through the execution phases� up to the point of de­
mise� can provide valua�le data on kinetic quantifica­
tion of pharmacologically­induced cell death. It would 
also offer a superior sensitivity and accuracy allowing 
one to assess dynamics of the apoptotic process and 
enhance the understanding of the molecular pro­
cesses underlying the apoptosis and other cell death 
modes [��� ��]. Limitations imposed �y conventional 
analytical techniques and �ioassays are� however� 
often prohi�itive for the kinetic analysis of single­cell 
responses to therapeutic compounds [��]. 
Only recently su�stantial progress has �een made 
in development of real­time fluorescent assays to pro­
vide cost­effective solution for automated and kinetic 
analysis of investigational anti­cancer agents in hema­
topoietic cancer cells [���7�]. There is a mushrooming 
evidence that cancer cells can �e continuously grown 
in the presence of inert fluorescent pro�es and imaged 
in a time­lapse mode or intermittently sampled to provide 
the multiparameter and kinetic profile of anti­cancer 
drug action [���7�]. A su�stantial reduction of sample 
processing steps and avoidance of washing protocols 
achieved with such kinetic protocols greatly facilitates 
the preservation of fragile cell su�populations [���7�].
In this context cyanine �YTO pro�es discussed 
under the previous su�title of this review have �een 
recently reported to �e inert and safe for tagging 
tumor cell over extended periods of time [��]. When 
preloaded into cells or continuously present in me­
dium� �YTOs do not interfere with cell via�ility while 
their intracellular retention can �e easily monitored 
for kinetic analysis of caspase­dependent apoptosis. 
�YTO ��­�ased sorting of intact apoptotic cells pro­
vides also an innovative approach to supravitally track 
progression of apoptotic cascade [��]. It has also 
�een reported that many organic fluorescent pro�es 
such as PI� �YTOX Green� �YTOX Red and YO­PRO 
� allow for a non­invasive tracking of cell death events 
over extended periods of time without compromising 
cell via�ility or interfering with cytotoxic drug action 
[����9]. Fluorescent annexin V conjugates represent 
yet another promising class of markers that do not 
adversely affect normal cellular physiology and can 
�e used in real­time protocols [7�]. The low­dose� 
continuous la�eling procedure not only provides simi­
lar results to a standard end­point staining protocol� 
�ut also allows a straightforward adaptation for innova­
tive La�­on­a­Chip microfluidic platforms with minimal 
protocol modifications [��� �7�7�].
As discussed earlier in this review several approaches 
to track caspase activation in living cells have �een de­
��� Experimental Oncology ��� �������� ���� ��eptem�er�
veloped. Among them are cell permea�le fluorogenic 
caspase su�strates such as PhiPhiLux� NucView �88 and 
FLICA [�7� ����7� 7�� 7�]. They are all relatively nontoxic 
to live cells �ut identify cells with activated caspases. 
By virtue of slowing down the process of disintegration 
of apoptotic cells �“stathmo­apoptosis”� FLICA can 
�e used to estimate kinetics apoptosis in cell populations 
[7�]. Because of paucity of fluorescent pro�es that can 
�e applied to measure extent of apoptosis in living organ­
isms the use in vivo FLICA reagents �defined “FLIVO”� 
is of particular interest [7�� 7�].
Yet another group of the pro�es applica�le to live 
cells are also already mentioned tandem molecules ex­
ploiting FRET of fluorescent proteins [�8� �9� 7��78]. 
These pro�es can �e reportedly used in real­time 
or near real­time assays featuring superior sensitivity 
and wealth of information as compared to standard 
end­point assays [7��78]. 
In closing the recent reports on innovative real­time 
�ioassays provide a rationale for the development 
of a new generation of �ioanalytical techniques with 
vast applications for tracking of differences in stochas­
tic cell death sensitivity that often remain undetecta�le 
with conventional end­point analysis.
CONCLUSIONS AND FUTURE OUTLOOK
During the past decade mechanisms underlying 
cell death have entered into a focus of interest of many 
researchers in diverse fields of �iomedicine and �io­
technology. Considera�le progress is currently �eing 
made in our understanding of a diversity of existing 
modes of programmed cell death. Burgeoning data 
show that although the elimination of many cells relies 
heavily on classical apoptotic pathways� the alterna­
tive� quasi­apoptotic and non­apoptotic mechanisms� 
may also �e involved in a plethora of �iological pro­
cesses. In this context� there is an ever­increasing de­
mand for convenient analytical tools to rapidly quantify 
and characterize diverse cell demise modes. �ince 
cell death is a stochastic process� high­throughput 
single­cell analysis platforms are of essence to deliver 
meaningful insights into intrinsically heterogeneous 
cell populations. Development of virtually inert fluo­
rescent pro�es with enhanced photosta�ility would 
open up new horizons for many functional and real­
time cytometric assays. There is also a strong reason 
to �elieve� that progress in novel technologies like 
imaging cytometry including laser scanning cytometry 
�L�C� and flow imaging cytometry� multispectral im­
aging cytometry and spectroscopic cytometry is just 
a prelude to a major transformation that the field will 
experience in the coming years. 
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